Back to companies
Lexaria Bioscience Corp.
LEXXCANASDAQPharmaceuticals & HealthcareLexaria Bioscience Corp.
Revenue
$705,923
YoY +52.0%
Operating income
-$11.9mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API